These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
615 related items for PubMed ID: 18042482
1. Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes. Orzeck EA, Shi N, Blumentals WA. Clin Ther; 2007 Oct; 29(10):2246-55. PubMed ID: 18042482 [Abstract] [Full Text] [Related]
2. Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study. Blumentals WA, Schulman KL. Curr Med Res Opin; 2007 Dec; 23(12):2961-70. PubMed ID: 17939881 [Abstract] [Full Text] [Related]
3. Effects of oseltamivir on influenza-related complications in children with chronic medical conditions. Piedra PA, Schulman KL, Blumentals WA. Pediatrics; 2009 Jul; 124(1):170-8. PubMed ID: 19564297 [Abstract] [Full Text] [Related]
4. Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study. Nordstrom BL, Oh K, Sacks ST, L'Italien GJ. Antivir Ther; 2004 Apr; 9(2):187-95. PubMed ID: 15134180 [Abstract] [Full Text] [Related]
5. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Arch Intern Med; 2003 Jul 28; 163(14):1667-72. PubMed ID: 12885681 [Abstract] [Full Text] [Related]
6. Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005. Peters PH, Moscona A, Schulman KL, Barr CE. Medscape J Med; 2008 Jun 04; 10(6):131. PubMed ID: 18679536 [Abstract] [Full Text] [Related]
7. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb 04; 15(81):21-30. PubMed ID: 16548114 [Abstract] [Full Text] [Related]
8. Factors associated with early hospital discharge of adult influenza patients. Lee N, Chan PK, Choi KW, Lui G, Wong B, Cockram CS, Hui DS, Lai R, Tang JW, Sung JJ. Antivir Ther; 2007 Feb 04; 12(4):501-8. PubMed ID: 17668558 [Abstract] [Full Text] [Related]
10. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment. Smith JR, Sacks S. Int J Clin Pract; 2009 Apr 04; 63(4):596-605. PubMed ID: 19335705 [Abstract] [Full Text] [Related]
15. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases. Casscells SW, Granger E, Kress AM, Linton A, Madjid M, Cottrell L. Circ Cardiovasc Qual Outcomes; 2009 Mar 04; 2(2):108-15. PubMed ID: 20031822 [Abstract] [Full Text] [Related]
17. Patients hospitalized with 2009 pandemic influenza A (H1N1) - New York City, May 2009. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2010 Jan 08; 58(51):1436-40. PubMed ID: 20057350 [Abstract] [Full Text] [Related]
18. Oseltamivir for treatment of influenza in infants less than one year: a retrospective analysis. Siedler K, Skopnik H. Pediatr Infect Dis J; 2010 Jun 08; 29(6):495-8. PubMed ID: 20035245 [Abstract] [Full Text] [Related]
19. Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomes. Postma MJ, Beardsworth P, Wilschut JC. J Med Econ; 2008 Jun 08; 11(4):743-68. PubMed ID: 19450079 [Abstract] [Full Text] [Related]